BioSpace News Archive

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today reported financial and operational highlights for the fourth quarter and year-ended Dec. 31, 2019.

Digipath, Inc. (OTCQB: DIGP) (“DIGP” or the “Company”), a leading independent analytical testing laboratory, data analytics and technology firm focused on the cannabis and hemp markets, is pleased to announce the closing of its acquisition of VSSL Enterprises Ltd. (“VSSL”). VSSL, located in Kelowna, B.C., is a provider of agritech consulting solutions in the areas of cannabis genetics, tissue culture, cultivation, analytical testing and predictive tools.

NuProbe Global, a global molecular diagnostics company based in Shanghai and Suzhou, China and Houston, TX, today announced it has entered into a collaboration agreement with QIAGEN to develop next-generation sequencing (NGS)-based cancer diagnostic tests for non-invasive liquid biopsy.

Kaiser Permanente is providing $1 million to increase capacity for preventing and treating cases of COVID-19, the disease caused by the novel coronavirus, within the nation’s homeless population in a collaboration with the National Health Care for the Homeless Council.

Celavet has previously collaborated with Dr. Watts to evaluate OK100 stem cells for treatment of equine tendon injuries

Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of Oncometrix’s customer base, as discussed in Precipio’s recent announcement.

Jvion, a leader in clinical AI, announced that it has initiated a data analysis project to identify patterns tied to the spread of viruses similar to COVID-19 that cause acute respiratory illness.

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today released a statement on H.R. 6201, the Families First Coronavirus Response Act, as passed by the House of Representatives on March 14, 2020.

Canada Health Infoway and Allscripts Healthcare Solutions announced that Allscripts Sunrise™ has achieved Infoway certification under the 2017 Edition Release 2 of pre-implementation certification requirements.

As part of its contribution to reducing the spread of the COVID-19 (coronavirus) pandemic, Vivify Health, the developer of the nation’s leading connected care platform for remote patient care, today announced the availability of new COVID-19 Screening, Self-Isolation and Monitoring Pathways for its Vivify +Go mobile solution.